Skip to main content
. Author manuscript; available in PMC: 2016 Jan 18.
Published in final edited form as: Breast Cancer Res Treat. 2014 May 22;146(1):25–40. doi: 10.1007/s10549-014-2989-4

Fig. 2.

Fig. 2

a Kaplan–Meier curves demonstrating the recurrence probability for the UHCMC TMA patient population stratified by MMP7 staining. Positive MMP7 staining is associated with significantly shorter time to recurrence (P = 0.03). b In the Hatzis patient cohort, the time to metastatic recurrence is significantly shorter (P = 0.0004) in patients with elevated MMP7 expression. c In the Bos patient cohort, mean expression of MMP7 is significantly higher (P = 0.003) in primary tumors of breast cancer patients that had metastases to the brain and/or lung versus patients that had bone metastases. d Kaplan– Meier curves demonstrating a significantly shorter time to metastasis to the brain and/or lung (P = 0.02) in association with elevated MMP7 expression in the Bos cohort